vs
Lakeside Holding Ltd（LSH）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是Lakeside Holding Ltd的1.6倍（$11.1M vs $7.0M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -22.6%，领先239.2%），Lakeside Holding Ltd同比增速更快（95.0% vs -48.8%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
LSH vs NREF — 直观对比
营收规模更大
NREF
是对方的1.6倍
$7.0M
营收增速更快
LSH
高出143.9%
-48.8%
净利率更高
NREF
高出239.2%
-22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $11.1M |
| 净利润 | $-1.6M | $24.0M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -21.3% | — |
| 净利率 | -22.6% | 216.6% |
| 营收同比 | 95.0% | -48.8% |
| 净利润同比 | 18.7% | 58.7% |
| 每股收益（稀释后） | $-0.08 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHNREF
| Q4 25 | $7.0M | $11.1M | ||
| Q3 25 | $6.1M | $12.5M | ||
| Q2 25 | $6.3M | $12.1M | ||
| Q1 25 | $3.8M | $11.5M | ||
| Q4 24 | $3.6M | $21.7M | ||
| Q3 24 | $4.1M | $12.5M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $-12.8M |
净利润LSHNREF
| Q4 25 | $-1.6M | $24.0M | ||
| Q3 25 | $-1.4M | $50.9M | ||
| Q2 25 | $-893.1K | $22.3M | ||
| Q1 25 | $-1.1M | $26.0M | ||
| Q4 24 | $-1.9M | $15.2M | ||
| Q3 24 | $-1.3M | $23.3M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $-14.6M |
毛利率LSHNREF
| Q4 25 | 27.2% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率LSHNREF
| Q4 25 | -21.3% | — | ||
| Q3 25 | -20.8% | — | ||
| Q2 25 | -8.9% | — | ||
| Q1 25 | -28.2% | — | ||
| Q4 24 | -55.6% | — | ||
| Q3 24 | -32.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率LSHNREF
| Q4 25 | -22.6% | 216.6% | ||
| Q3 25 | -22.2% | 407.0% | ||
| Q2 25 | -14.2% | 184.5% | ||
| Q1 25 | -28.2% | 225.6% | ||
| Q4 24 | -54.1% | 69.9% | ||
| Q3 24 | -32.7% | 186.4% | ||
| Q2 24 | — | 179.7% | ||
| Q1 24 | — | 114.3% |
每股收益（稀释后）LSHNREF
| Q4 25 | $-0.08 | $0.47 | ||
| Q3 25 | $-0.09 | $1.14 | ||
| Q2 25 | $-0.11 | $0.54 | ||
| Q1 25 | $-0.14 | $0.70 | ||
| Q4 24 | $-0.26 | $0.71 | ||
| Q3 24 | $-0.18 | $0.74 | ||
| Q2 24 | — | $0.40 | ||
| Q1 24 | — | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $31.1M |
| 总债务越低越好 | $2.4M | $771.2M |
| 股东权益账面价值 | $12.2M | $388.0M |
| 总资产 | $24.3M | $5.3B |
| 负债/权益比越低杠杆越低 | 0.20× | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资LSHNREF
| Q4 25 | $1.6M | $31.1M | ||
| Q3 25 | $4.5M | $17.9M | ||
| Q2 25 | $5.0M | $9.1M | ||
| Q1 25 | $1.5M | $19.2M | ||
| Q4 24 | $1.1M | $3.9M | ||
| Q3 24 | $2.7M | $34.7M | ||
| Q2 24 | — | $4.3M | ||
| Q1 24 | — | $13.5M |
总债务LSHNREF
| Q4 25 | $2.4M | $771.2M | ||
| Q3 25 | $2.4M | $720.9M | ||
| Q2 25 | $1.4M | $815.6M | ||
| Q1 25 | $774.2K | $831.5M | ||
| Q4 24 | $784.8K | $799.3M | ||
| Q3 24 | $589.9K | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益LSHNREF
| Q4 25 | $12.2M | $388.0M | ||
| Q3 25 | $7.0M | $375.4M | ||
| Q2 25 | $2.8M | $348.2M | ||
| Q1 25 | $749.8K | $343.7M | ||
| Q4 24 | $1.6M | $336.5M | ||
| Q3 24 | $3.6M | $335.8M | ||
| Q2 24 | — | $327.5M | ||
| Q1 24 | — | $327.1M |
总资产LSHNREF
| Q4 25 | $24.3M | $5.3B | ||
| Q3 25 | $18.6M | $5.3B | ||
| Q2 25 | $14.4M | $5.4B | ||
| Q1 25 | $9.9M | $5.4B | ||
| Q4 24 | $9.8M | $5.4B | ||
| Q3 24 | $10.8M | $5.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | — | $7.1B |
负债/权益比LSHNREF
| Q4 25 | 0.20× | 1.99× | ||
| Q3 25 | 0.35× | 1.92× | ||
| Q2 25 | 0.48× | 2.34× | ||
| Q1 25 | 1.03× | 2.42× | ||
| Q4 24 | 0.48× | 2.38× | ||
| Q3 24 | 0.16× | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LSHNREF
| Q4 25 | $-453.5K | $-4.5M | ||
| Q3 25 | $-4.0M | $8.1M | ||
| Q2 25 | $-483.7K | $3.3M | ||
| Q1 25 | $-238.3K | $16.0M | ||
| Q4 24 | $-530.2K | $4.4M | ||
| Q3 24 | $-1.4M | $14.7M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | — | $17.7M |
自由现金流LSHNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-497.4K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-560.5K | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率LSHNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -7.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.6% | — | ||
| Q3 24 | -34.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度LSHNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率LSHNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
NREF
暂无分部数据
